Moolec Science (MLEC) Non-Current Debt (2023 - 2025)
Moolec Science's (MLEC) quarterly Non-Current Debt came in at $1.3 million in Q2 2025, down 98.94% year-on-year from $127.2 million in Q2 2024, and down 98.94% quarter-over-quarter from $127.2 million in Q2 2024.
Moolec Science (MLEC) Non-Current Debt (2023 - 2025) Analysis & Trends
Moolec Science has disclosed Non-Current Debt across 3 years of filings, most recently posting $1.3 million for Q2 2025.
- Non-Current Debt for Q2 2025 came in at $1.3 million, down 98.94% year-over-year; the trailing twelve-month figure through Jun 2025 was $1.3 million (down 98.94% YoY), and the FY2025 annual result was $1.3 million, down 98.94% from the prior year.
- Non-Current Debt came in at $1.3 million for Q2 2025 at Moolec Science, down from $127.2 million in the prior quarter.
- In the past five years, Non-Current Debt ranged from a high of $127.2 million in Q2 2024 to a low of $1.2 million in Q1 2023.
- The 3-year median for Non-Current Debt is $2.5 million (2023), against an average of $28.0 million.
- Across the five-year window, Non-Current Debt jumped 4897.49% in 2024 and tumbled 98.94% in 2025, its largest moves.
- Moolec Science's Non-Current Debt stood at $7.8 million in 2023, then surged by 1521.87% to $127.2 million in 2024, then sank by 98.94% to $1.3 million in 2025.
- The last three Non-Current Debt figures came in at $1.3 million (Q2 2025), $127.2 million (Q2 2024), and $7.8 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 319.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Moolec Science | 6.98 Bn | 6.98 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 1.35 Mn |
| Jun 30, 2025 | 1.35 Mn |
| Jun 30, 2024 | 127.25 Mn |
| Jun 30, 2024 | 127.25 Mn |
| Dec 31, 2023 | 7.85 Mn |
| Dec 31, 2023 | 7.85 Mn |
| Jun 30, 2023 | 2.55 Mn |
| Jun 30, 2023 | 2.55 Mn |
| Mar 31, 2023 | 1.18 Mn |
| Mar 31, 2023 | 1.18 Mn |